HPV vaccine may not be cost-effective in adult populations aged over 26 years
This study suggests that HPV vaccination over age 26 years provides limited health benefits at a high cost.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer Vaccines | Cervical Cancer Vaccine | Genital Warts | Human Papillomavirus (HPV) | Study | Vaccines